Navigation Links
FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab)
Date:5/29/2009

ORLANDO, Fla., May 29 /PRNewswire-FirstCall/ -- GlaxoSmithKline [NYSE: GSK] and Genmab A/S [OMX: GEN] today announced that the United States Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 10 to three that the ARZERRA(TM) (ofatumumab) data are reasonably likely to predict clinical benefit for patients with chronic lymphocytic leukemia (CLL) whose disease is refractory to fludarabine and alemtuzumab. Ofatumumab is an investigational treatment.

"The committee's positive vote in support of ofatumumab is a potential milestone for patients with CLL. While current initial treatments for CLL can provide prolonged remissions, some patients will progress rapidly and relapse, which highlights the need for new therapies," said Debasish Roychowdhury, M.D., Senior Vice President and Head, Medicines Development, GlaxoSmithKline Oncology. "We look forward to working with the FDA towards an approval for ofatumumab."

CLL is the most common form of adult leukemia in the Western world, and the treatment of patients with relapsed disease remains a significant challenge. Patients who have not responded to current standard therapies, or whose disease has returned following prior treatments, typically experience poorer clinical outcomes such as infections and death. Less than 25 percent of CLL patients who are resistant to current treatments respond to available therapies.

"The positive vote by ODAC confirms that ofatumumab may offer a new treatment option for patients who have received prior therapies with this type of CLL," said Lisa N. Drakeman, Ph.D., Chief Executive Officer of Genmab. "Today's vote is positive affirmation for this medicine, which is a result of years of dedicated research and collaboration between Genmab and GSK."

The advisory committee made its decision based on an interim analysis of a pivotal trial that was presented at the American Society of He
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Advisory Panel Recommends Approval of the SEDASYS(R) System
2. Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes
3. FDA Advisory Committee Recommends Approval of Multaq(R) (dronedarone)
4. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
5. AstraZeneca Responds to FDA Joint Advisory Committees Recommendation on SYMBICORT(R)
6. Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout
7. New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties
8. Arpida Comments on FDAs Anti-infective Drugs Advisory Committee Outcome
9. Arpida Announces Review of Iclaprim NDA by FDA Advisory Committee in November 2008
10. News Media Advisory: Worlds Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments
11. FDA Advisory Committee Unanimously Recommends Approval of Ustekinumab for Treatment of Moderate to Severe Plaque Psoriasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... TAUNTON, Massachusetts , 21. Mai 2013 ... Inc. („OSI"), die die Firmen OMNIlife science® ... Tochtergesellschaften zählt, hat zwei neue, erfahrene Mitglieder ... Mayer , eine erfahrene Führungspersönlichkeit aus ... übernehmen. David Johnson , ...
(Date:5/21/2013)...  Tom Daulton, CEO of Mammotome, a division of Devicor ... the Cincinnati chapter of the Association ... local top executive who is also a breast cancer survivor, ... in March of 2010. Daulton will be presented with the ... Huntington Bank, on May 22. The ACG Deal ...
(Date:5/21/2013)... and PHILADELPHIA , May 21, 2013 ... its new corporate image and impressive new product developments at ... . "After ten years of unerring focus on product ... felt the need to mark the occasion," said founding director ... we have some interesting developments of benefit to our clients ...
Breaking Medicine Technology:Orthopaedic Synergy Inc. meldet bedeutenden Zuwachs im Vorstand 2Orthopaedic Synergy Inc. meldet bedeutenden Zuwachs im Vorstand 3Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year 2Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year 3Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 2Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 3
... , HOPKINTON, Mass. , Jan. 25 ... provider of tools and services for drug discovery and life ... and several new platform innovations at the LabAutomation 2010 conference ... the flexibility of its predecessors with powerful new innovations including: ...
... , NEW YORK , Jan. 25 ... therapeutics for chronic fibrotic and metabolic diseases, today announced the ... financing by its majority shareholder Genextra S.p.A. , Dr. ... is recognition of the success we have had advancing our ...
Cached Medicine Technology:Caliper Life Sciences Introduces Sciclone(R) G3 Liquid Handler 2Caliper Life Sciences Introduces Sciclone(R) G3 Liquid Handler 3Intercept Pharmaceuticals Raises $25 Million Series B Financing 2Intercept Pharmaceuticals Raises $25 Million Series B Financing 3
(Date:5/21/2013)... GA (PRWEB) May 21, 2013 Patients of ... Care who have lost teeth due to gum disease and ... surgery for gum disease treatment with laser gum surgery. ... which have the highest success rate out of all tooth ... (LANAP) is a relatively new procedure cleared by the Food ...
(Date:5/21/2013)... Kan. Primary care practice transformation on a ... care reform efforts aimed at achieving better outcomes, ... emerging evidence that transformation toward the patient-centered medical ... health care environment, the U.S. Department of Health ... Quality funded 14 studies to learn more about ...
(Date:5/21/2013)... May 21, 2013 Parker Waichman LLP, ... of victims injured by defective medical devices, is addressing ... Joint Surgery on May 15, 2013. The study found ... identify complications that occur in patients with metal-on-metal hip ... ( http://www.jbjs.org/article.aspx?articleid=1684770 ) , “We’ve known ...
(Date:5/21/2013)... 21, 2013 Artisan Business Group ... Summit: Dealmakers Conference in Long Beach, California on ... on exploring alternative finance through EB-5 immigrant investors ... legal and economic information, and updates to project ... within the EB-5 industry. , "Our goal ...
(Date:5/21/2013)... 2013 Arizona State University is ... to develop their ideas into solutions, products and ... The university is recruiting participants for AREA48 (Applied ... that provides early-stage entrepreneurs with opportunities to access ... to anyone, ASU is particularly seeking participation from ...
Breaking Medicine News(10 mins):Health News:Shenk Dental Care Stimulates Bone Growth for Gum Disease Patients Seeking Dental Implants with Laser Gum Surgery in Atlanta, GA 2Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 2Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 3Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 4Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 5Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 6Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 2Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 3Health News:Artisan Business Group to Host EB-5 Investment Conference in Long Beach, California 2Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 2Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 3Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 4
... the ban on mercury based flu vaccines given to pregnant ... six weeks . This decision was made due to a ... free children's vaccine is manufactured by Sanofi pasteur, and the ... speed up production to meet the state's need. ,The ...
... new artificial pump along with the intake of certain drugs ... say scientists in Britain.// ,The temporary pumps, known ... patients with severe heart failure while they await transplantation, reported ... on the work of one of the heart's four chambers, ...
... biggest killer disease in the UK during the 1800s has made ... to 2005. //Th number of cases have been rising from the ... , causing great concern to government health agencies. ,The ... Louis Stevenson , was thought to have been conquered by very ...
... unhappy lot because nearly 50 percent of the clan is ... in their careers.// A new study has claimed that nearly ... of chemicals, soaps and shampoos that render constantly moist hands., ... careers, unable to carry on with their jobs when the ...
... abused in early stages of life may grow up to ... University of Chicago. //This study was conducted on baby rhesus ... may lead to the production of less seratonin, a chemical ... causes anxiety and depression.It may also lead to impulsive aggression ...
... down with acute symptoms of dengue, later confirmed positive for ... alarming figure of 741. ,Nearly 31 deaths have ... Peshawar. The National Institute of Health (NIH) has reiterated via ... the disease are pouring in from all over Pakistan which ...
Cached Medicine News:Health News:New Device May Help Heal A Failing Heart 2Health News:TB Returns , Sharp Rise In Cases In UK 2Health News:Hair-raising issues of hairdressers 2Health News:An abused child may grow up to be an abusive parent 2Health News:An abused child may grow up to be an abusive parent 3
Valleylab Surgistat II generator provides exceptional performance, reliability, and safety benefits in a compact, easy to use unit....
Sabre 180, 230V, 50Hz is a powerful niche generator....
Microcontroller-based isolated electrosurgical generator, designed for all general purpose surgical procedures. Unit includes: Instant Response technology, adaptive REM system, isolated output, CEM c...
Maddox rod and occluder...
Medicine Products: